You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Medtronic
AstraZeneca
McKinsey
Moodys
Boehringer Ingelheim
Johnson and Johnson

Last Updated: July 3, 2020

DrugPatentWatch Database Preview

TERIL Drug Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

When do Teril patents expire, and what generic alternatives are available?

Teril is a drug marketed by Taro and is included in two NDAs.

The generic ingredient in TERIL is carbamazepine. There are twenty-seven drug master file entries for this compound. Thirty-five suppliers are listed for this compound. Additional details are available on the carbamazepine profile page.

US ANDA Litigation and Generic Entry Outlook for Teril

A generic version of TERIL was approved as carbamazepine by TARO on October 3rd, 1996.

  Start Trial

US Patents and Regulatory Information for TERIL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Taro TERIL carbamazepine SUSPENSION;ORAL 076729-001 Sep 20, 2004 AB RX No No   Start Trial   Start Trial   Start Trial
Taro TERIL carbamazepine TABLET;ORAL 076525-001 Sep 26, 2003 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
AstraZeneca
McKinsey
Moodys
Boehringer Ingelheim
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.